金信诺 reported revenue of ¥1.49B for the period ended 2026-06-30, +21.8% year on year. Net income was ¥0.02B, a 1.2% net margin on a 19.0% gross margin. The largest revenue line is 通信组件及连接器 at 56% of the total. Free cash flow for the period was ¥-0.18B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.49B | +21.8% |
| Gross profit | ¥0.28B | — |
| Operating income | ¥0.02B | — |
| Net income | ¥0.02B | — |
| Gross margin | 19.0% | Net margin 1.2% |
| Revenue Q/Q | +20.9% | — |
| Segment | Revenue | Share |
|---|---|---|
| 通信组件及连接器 | ¥0.84B | 56.5% |
| 通信电缆及光纤光缆 | ¥0.52B | 34.9% |
| PCB系列 | ¥0.11B | 7.1% |
| 其他(补充) | ¥0.01B | 1.0% |
| 卫星及无线通讯产品 | ¥0.01B | 0.6% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥1.21B | 81.0% |
| R&D | ¥0.10B | 6.4% |
| SG&A | ¥0.15B | 10.2% |
| Tax & other | ¥-0.00B | -0.2% |
| Item | Amount |
|---|---|
| Total assets | ¥5.40B |
| Total liabilities | ¥2.98B |
| Shareholders' equity | ¥2.42B |
| Equity / assets | 44.9% |
| Operating cash flow | ¥-0.12B |
| Capital expenditure | ¥0.07B |
| Free cash flow | ¥-0.18B |
| Cash conversion (OCF / net income) | -608% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
卫宁健康 ・ 仟源医药 ・ 常山药业 ・ 星星科技 ・ 开山股份 ・ 精锻科技 ・ 新天科技 ・ 新莱应材 ・ 雅本化学 ・ 隆华科技 ・ 佳创视讯 ・ 通光线缆
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies